Selective decontamination of the digestive tract: All questions answered?

Critical Care

Volumn 7, Issue 3, 2003, Pages 203-205

  Bonten, Marc J M ^a   Joore, Hans C A ^a   de Jongh, Bartelt M ^b   Kluytmans, Jan ^c   Kuijper, Ed J ^d   van Leeuwen, Henk J ^a   de Smet, Anne Marie G A ^a   Vandenbroucke Grauls, Christina ^e  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c AMPHIA HOSPITAL   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM; CEFOTAXIME; CEPHALOSPORIN; CIPROFLOXACIN; METICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CLINICAL PRACTICE; DIGESTIVE SYSTEM INFECTION; DISEASE TRANSMISSION; ENTEROCOCCUS; GENE MUTATION; GRAM NEGATIVE BACTERIUM; HOSPITAL HYGIENE; HUMAN; INFECTION CONTROL; INTENSIVE CARE; INTENSIVE CARE UNIT; INTESTINE FLORA; LENGTH OF STAY; MEDICAL SPECIALIST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHODOLOGY; MICROBIOLOGY; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROPHYLAXIS; SURVIVAL; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DECONTAMINATION; DIGESTIVE SYSTEM; DRUG RESISTANCE, BACTERIAL; HUMANS; INFECTION CONTROL; INTENSIVE CARE; OUTCOME ASSESSMENT (HEALTH CARE); RESEARCH DESIGN; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037972383     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc1881     Document Type: Article

References (8)

1. Bonten MJ, Kullberg BJ, van Dalen R, Girbes AR, Hoepelman IM, Hustinx W, van der Meer JW, Speelman P, Stobberingh EE, Verbrugh HA, Verhoef J, Zwaveling JH: Selective digestive decontamination in patients in intensive care. The Dutch Working Group on Antibiotic Policy. J Antimicrob Chemother 2000, 46:351-362.
2. de Jonge E, Schultz MJ, Spanjaard L, Bossuyt PM, Vroom MB, Dankert J, Kesecioglu J: European Society of Intensive Care Medicine, 15th Annual Congress (Barcelona): effects of selective decontamination of the digestive tract on mortality and antibiotic resistance [abstract 30]. Intensive Care Med 2002, 28(suppl 1):S12.
3. Bonten MJM, Slaughter S, Ambergen AW, Hayden MK, van Voorhis J, Nathan C, Weinstein RA: The role of 'colonization pressure' in the spread of vancomycin-resistant enterococci. An important infection control variable. Arch Intern Med 1998, 158:1127-1132.
4. van den Braak N, Ott A, van Belkum A, Kluytmans JAJW, Koeleman JGM, Spanjaard L, Voss A, Weersink AJL, Vandenbroucke-Grauls CMJE, Buiting AGM, Verbrugh HA, Endtz HP: Prevalence and determination of fecal colonization with vancomycin-resistant enterococcus in hospitalized patients in the Netherlands. Infection Control Hospital Epidemiol 2000, 21:520-524.
5. Bonten MJ, Willems R, Weinstein RA: Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 2001, 1:314-325.
6. Brun-Buisson C, Legrand P, Rauss A, Richard C, Montravers F, Besbes M, Meakins JL, Soussy CJ, Lemaire F: Intestinal decontamination for control of nosocomial multiresistant Gram-negative bacilli: study of an outbreak in an intensive care unit. Ann Intern Med 1989, 110:873-881.
7. van Belkum A, Goessens W, van der Schee C, Lemmens-den Toom N, Vos MC, Cornelissen J, Lugtenburg E, de Marie S, Verbrugh H, Lowenberg B, Endtz H: Rapid emergence of ciprofloxacin-resistant enterobacteriaceae containing multiple gentamicin resistance-associated integrons in a Dutch hospital. Emerg Infect Dis 2001, 7:862-871.
8. Mooij M, Schouten I, Schultsz C, Savelkoul PH, Reinders E, Vos M, van Belkum A, Vandenbroucke-Grauls C: Drug-resistance associated integrons in ciprofloxacin-resistant Escherichia coli. In Proceedings of the 42nd International Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, San Diego, September 2002:124.